Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitCandida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansCurrent and emerging azole antifungal agentsAntifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitroAntifungal resistance in pathogenic fungiDouble-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsEpidemiology of invasive candidiasis: a persistent public health problemClinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY ParBloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use.Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital.Candida and invasive candidiasis: back to basics.Nisin Z inhibits the growth of Candida albicans and its transition from blastospore to hyphal form.The ins and outs of DNA fingerprinting the infectious fungiCandida dubliniensis: characteristics and identification.Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolatesThirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center.Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensisA pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans.Apoptosis induced by environmental stresses and amphotericin B in Candida albicans.Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit.Oral colonization by Candida albicans.Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes.Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identificationElucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3.Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episodeOutbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India.Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis.Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.Prospective study of Candida species in patients at a comprehensive cancer centerGastrointestinal colonization by Candida albicans mutant strains in antibiotic-treated mice.Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.Fungal endocarditis: evidence in the world literature, 1965-1995.Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth.Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm.The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion
P2860
Q21194915-EC1131F2-8DAF-465B-B66B-86BF95054C17Q24550731-98F2F3BF-E827-4032-842E-DB5D978632C1Q24550733-6C0BD641-7224-4C7C-A99E-5A53C64E21BBQ24671525-1D65D352-B377-46DB-BB0A-B7AC8AAEB557Q28208165-E0AF7D00-63CC-4472-BD95-AAF0D86E0BF2Q28362691-176ECCA1-5CA8-4B63-B1C3-DB3C6FCBA74BQ29616758-25586215-6261-460B-9367-E294687E226AQ30433993-3A93019E-DF5E-4EC5-97B4-5D99F1CA4EE1Q30453440-8C7FB22B-7AFF-4340-8BDF-4F021667F0A8Q30453663-401B0656-C42D-4F9E-886E-5997A8B2F325Q31918072-9B1B27DB-6E90-4E1F-B0E3-511B9E03F8A0Q32101258-A9DBF458-800A-465F-9E2F-96A922ADEC56Q33351140-69AD9BD5-504A-45FB-8F58-588A29309541Q33400077-E17524EF-C45C-470C-A043-4DA25FB61E49Q33555593-6C2CD763-9227-4F95-9C2C-AC2735E73CDEQ33655501-1D22D51B-6EE5-448E-808B-34552FD2CB8FQ33668650-3017D221-C530-453B-9421-F52F1678D26FQ33691981-4480748F-73B4-4B25-9B64-CCF1FB62B104Q33693370-39D05E4B-88E6-413A-A74C-A42D6D36F166Q33694469-9D763566-0A1B-48B7-B82B-9C0957890ABFQ33709290-F43AA4ED-087F-4934-9EA2-39C1289F1A37Q33716986-499FA0AB-CB1C-4310-A5AA-0725A5BF0720Q33856434-1BCF6AE7-EE3F-423E-B997-04A5B81D9DFFQ33888286-BDC0960E-050B-403A-939E-87FF094A7DC7Q33958156-74932DC8-595D-497A-879A-6D7B2E0E67D6Q33959121-392657CB-51D2-4FC9-AC95-8440C767F41DQ33960566-F022A776-BD73-4A1A-9321-DF5CC6F40CA1Q33962423-180C1677-0DE5-4E3C-8CB9-D215949C07D9Q33965906-07B754C4-F069-492C-8051-A8FE16A26EBFQ33969896-AF233D64-6186-4E1B-B7B9-74D96E474523Q33972156-5574B3A9-E902-40F1-B3E2-2268659783CBQ33974582-E61779D1-E8D5-43E5-BF32-C0D1A089392EQ33981130-CFDA4D43-58DC-4828-B5F8-AA99577EBF35Q33982572-9DCF6A15-0749-4417-A522-A8AB92DC8AA1Q33998896-52437306-8FDC-4D0B-988B-688B4B110422Q34008664-18FE85F0-AF80-47E5-B120-59A6491E6538Q34105375-2EBCA48F-1D75-4195-BCF5-BC5369AE5761Q34106442-99BF42BC-C6B1-474E-BC07-EBE69D862A2AQ34142527-C2158C3C-4F3F-4899-91E9-254A75CC7344Q34177651-B86F4EDD-2235-4C05-BF4F-FFE7257F0E4B
P2860
Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.
@en
type
label
Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.
@en
prefLabel
Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.
@en
P1476
Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.
@en
P2093
Pfaller MA
P304
P356
10.1093/CLINIDS/22.SUPPLEMENT_2.S89
P407
P478
22 Suppl 2
P577
1996-05-01T00:00:00Z